Werewolf Therapeutics (HOWL) Earnings Date, Estimates & Call Transcripts $1.07 +0.04 (+3.88%) Closing price 04:00 PM EasternExtended Trading$1.09 +0.02 (+1.50%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Werewolf Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 2Before Market OpensEstimatedActual EPS (Mar. 11) -$0.46 Missed By -$0.03 Consensus EPS (Mar. 11) -$0.43 Werewolf Therapeutics released Q4 2024 earnings on March 11, 2025, reporting an EPS of -$0.46, which missed the consensus estimate of -$0.43 by $0.03. With a trailing EPS of -$1.66, Werewolf Therapeutics' earnings are expected to decrease next year, from ($1.56) to ($1.92) per share. SEC 10-Q/10-K FilingHOWL Upcoming EarningsWerewolf Therapeutics' next earnings date is estimated for Friday, May 2, 2025, based off prior year's reporting schedules. Get Werewolf Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Werewolf Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataHOWL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.HOWL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Werewolf Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.17-$0.43-$0.80Q2 20252-$1.22-$0.45-$0.84Q3 20252-$0.99-$0.47-$0.73Q4 20252-$0.86-$0.30-$0.58FY 20258($4.24)($1.65)($2.95) Remove Ads Werewolf Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/2/2025(Estimated)-------3/11/2025Q4 2024-$0.43-$0.46 -$0.03-$0.46$1.00M-8/8/2024Q2 2024-$0.38-$0.43 -$0.05-$0.43$2.00M$1.14M5/3/2024Q1 2024-$0.35-$0.39 -$0.04-$0.39$5.00M$0.74M3/7/2024Q4 2023-$0.43-$0.33+$0.10-$0.33$2.75M$1.50M11/14/2023Q3 2023-$0.27-$0.23+$0.04-$0.23$15.60M$5.90M8/10/2023Q2 2023-$0.41-$0.14+$0.27-$0.14$3.05M$8.08M5/11/2023Q1 2023-$0.49-$0.34+$0.15-$0.34$3.05M$4.46M Werewolf Therapeutics Earnings - Frequently Asked Questions When is Werewolf Therapeutics's earnings date? Werewolf Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 2nd, 2025 based off last year's report dates. Learn more on HOWL's earnings history. Did Werewolf Therapeutics beat their earnings estimates last quarter? In the previous quarter, Werewolf Therapeutics (NASDAQ:HOWL) missed the analysts' consensus estimate of ($0.43) by $0.03 with a reported earnings per share (EPS) of ($0.46). Learn more on analysts' earnings estimate vs. HOWL's actual earnings. How can I view Werewolf Therapeutics's earnings report? Werewolf Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Werewolf Therapeutics generate each year? Werewolf Therapeutics (NASDAQ:HOWL) has a recorded annual revenue of $1.89 million. How much profit does Werewolf Therapeutics generate each year? Werewolf Therapeutics (NASDAQ:HOWL) has a recorded net income of -$37.37 million. HOWL has generated -$1.66 earnings per share over the last four quarters. What is Werewolf Therapeutics's EPS forecast for next year? Werewolf Therapeutics's earnings are expected to decrease from ($1.56) per share to ($1.92) per share in the next year. More Earnings Resources from MarketBeat Related Companies CTNM Earnings Results CKPT Earnings Results LFVN Earnings Results NMRA Earnings Results CRGX Earnings Results AMRN Earnings Results TNGX Earnings Results OCGN Earnings Results KOD Earnings Results CGC Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss Remove Ads This page (NASDAQ:HOWL) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Werewolf Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Werewolf Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
